Skip to main content
. Author manuscript; available in PMC: 2025 Sep 15.
Published in final edited form as: J Orthop Res. 2020 Jun 22;39(3):619–627. doi: 10.1002/jor.24770

TABLE 2.

Gait, WOMAC, and COMP data at baseline and 6-month follow-up

Variable Baseline Follow-up P
KAM1 (%Bw × Ht) 2.67 ± 0.76 2.47 ± 0.75 <.001
KAM impulse (%Bw × Ht × s) 1.06 ± 0.36 0.99 ± 0.35 .009
Walking speed (m/s) 1.20 ± 0.14 1.22 ± 0.16 .30
WOMAC Pain 75.5 ± 15.1 75.3 ± 21.4 .95
WOMAC Stiffness 64.5 ± 17.8 65.1 ± 22.7 .95
WOMAC Function 79.6 ± 18.0 81.9 ± 18.1 .78
Resting COMP (ng/mL) 2.70 ± 1.98 2.61 ± 1.73 .41
3.5-hour COMP (% of resting) 84.4 ± 11.1 82.5 ± 9.1 .52
5.5-hour COMP (% of resting) 79.4 ± 13.3 84.5 ± 13.2 .10

Note: P values presented are from respective paired Student’s t tests or Wilcoxon signed-rank tests (for nonnormally distributed data). Data presented as mean ± standard deviation. KAM1, KAM impulse, and walking speed presented as control shoe at baseline and variable-stiffness shoe at follow-up.

Abbreviations: COMP, cartilage oligomeric matrix protein; KAM, knee adduction moment; KAM1, first peak KAM; WOMAC, Western Ontario and McMaster Universities.